Acurx Pharmaceuticals, Inc. ACXP
1.36
0.00
0.00%
as of 25 Sep
- Market cap
- $7.6M
- P/E
- 0.0×
Follow ACXP
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | 1.48 | 6.82 | 15.71 | 4.55 | 2.53 | 1.19 | 3.18 |
Net Debt/EBITDA |
— | 0.42 | 0.69 | 1.01 | 0.75 | 0.51 | 0.26 | 0.93 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.67 | 0.73 | 0.39 | 0.62 | 0.67 | 0.74 | 0.85 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | (336.86%) | (261.25%) | (168.71%) | (122.61%) | (243.33%) | (534.03%) | (270.80%) | |
| — | (468.62%) | (159.85%) | (154.72%) | (106.87%) | (170.64%) | (243.85%) | (137.98%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | (723.51%) | (167.19%) | (102.72%) | (165.32%) | (312.38%) | (2,292.44%) | (151.21%) |
Average Days of Receivables |
— | — | — | — | — | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
— | (16.60) | (10.83) | (11.75) | (13.95) | (15.47) | (12.85) | (4.53) |
Cash per Share |
— | 10.34 | 10.26 | 30.36 | 16.85 | 11.80 | 4.59 | 5.04 |
Shareholders Equity per Share |
— | 3.41 | 8.73 | 29.08 | 13.53 | 7.37 | 0.76 | 3.52 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 3.41 | 8.73 | 29.08 | 13.53 | 7.37 | 0.76 | 3.52 |
Free Cash Flow |
— | (3.99) | (3.35) | (5.01) | (7.54) | (9.80) | (10.38) | (6.79) |
Working Capital |
— | 0.82 | 2.75 | 12.41 | 7.32 | 4.67 | 0.62 | 5.27 |
Net Current Asset Value |
— | 0.82 | 2.70 | 12.41 | 7.32 | 4.67 | 0.62 | 5.27 |
| Other line items | ||||||||
Quick Ratio |
— | 1.45 | 6.72 | 15.36 | 4.42 | 2.50 | 1.16 | 3.14 |
Cash ROIC |
— | (120.65%) | (57.03%) | (19.76%) | (45.91%) | (80.73%) | (240.26%) | (52.93%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | 0.00 | 0.00 |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (16.60) | (10.83) | (11.75) | (13.95) | (15.47) | (12.85) | (4.53) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | — | 0.09 | 0.05 |
Average Payables |
— | 0.86 | 0.86 | 0.65 | 1.45 | 2.55 | 3.14 | 2.83 |
Average Assets |
— | 1.27 | 2.88 | 8.24 | 11.32 | 8.54 | 5.78 | 5.77 |
Average Common Equity |
— | 1.76 | 1.76 | 7.56 | 9.86 | 5.99 | 2.64 | 2.94 |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates